GILD vs VIRT · P/E 18, rev $29.44B vs P/E 13, rev $2.88B
Gilead Sciences Inc (GILD) versus Virtu Financial, Inc. (VIRT) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Virtu Financial, Inc. (VIRT) is a capital markets company listed on US.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported VIRT revenue for 2024-12-31 was $2.88B. Net income was $534.5M. Revenue was up 25.4% from 2023-12-31 to 2024-12-31. VIRT currently screens at market cap $6.78B and trailing P/E 12.7.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. VIRT currently screens at market cap $6.78B and trailing P/E 12.7.
Not investment advice. Open the GILD and VIRT stock pages for the full models.
Not investment advice.